Two Massachusetts companies, Fenugreen and Dynamo Micropower, took home the grand prizes this week at Startup Open, a competition put on by the Kauffman Foundation that recognizes startups with high-growth potential. Cambridge, MA-based Fenugreen develops all-natural food packaging material called FreshPaper that’s designed to give produce two to four times the shelf life it sees … Continue reading “Fenugreen and Dynamo Micropower Nab Top Spots at Kauffman’s Startup Open”
Author: Erin Kutz
Erin Kutz has a background in covering business, politics and general news. She holds a bachelor’s degree in journalism from Boston University. Erin previously worked in the Boston bureau of Reuters, where she wrote articles on the investment management and mutual fund industries. While in college, she researched for USA Today reporter Jayne O’Donnell’s book, Gen Buy: How Tweens, Teens and Twenty-Somethings Are Revolutionizing Retail. She also spent a semester in Washington, DC, reporting Capitol Hill stories as a correspondent for two Connecticut newspapers and interning in the Money section of USA Today, where she assisted with coverage on the retail and small business beats. Erin got her first taste of reporting at Boston University’s independent student newspaper, as a city section reporter and fact checker and editor of the paper’s weekly business section.
AppBrick Is Out to Add Life To “Flat” E-Books with an Interactive Layer
Vijay Gaur sees the book going in the same direction that the mobile phone has. “We are converting a book into a platform,” says Gaur. “Your phone is becoming more powerful by applications. We are now applying that same concept to books.” That’s the idea behind his Medford, MA-based startup, AppBrick. The company, which graduated … Continue reading “AppBrick Is Out to Add Life To “Flat” E-Books with an Interactive Layer”
AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News
New England area biotechs had news this week on stock price, clinical data, new financings, and more. —AMAG Pharmaceuticals of Lexington, MA, saw its stock shoot up 18 percent to $16.21 on Monday after announcing its CEO Brian Pereira’s departure and its plans for reducing operating expenses. AMAG (NASDAQ: [[ticker:AMAG]]) has struggled in transitioning from … Continue reading “AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News”
Calling Entrepreneurs for Sound Off, Round 2, at 6×6: Six Cities, Six Big Tech Ideas
We want you. To tell our audience what you want to see for the innovation community here in Boston. At Xconomy’s upcoming conference, 6×6: Six Cities, Six Big Tech Ideas. The Dec. 1 program, which features one cool tech company from each of our six cities, already has a top-notch line-up of speakers, like keynoter … Continue reading “Calling Entrepreneurs for Sound Off, Round 2, at 6×6: Six Cities, Six Big Tech Ideas”
Shareaholic Inks Seed Investment, Introduces Tumblr Plug-in
[Updated 11/10/11 10:35 am. See below.] Shareaholic, a Cambridge, MA-based maker of plug-ins for sharing content on the Web, has collected a $1.9 million round of seed funding, which will go to expanding the company’s team and publisher network. [Story updated to include specific funding amount.] The money comes from a collection of big-name angel … Continue reading “Shareaholic Inks Seed Investment, Introduces Tumblr Plug-in”
Collabor’s Software for Outward Collaboration at Businesses Ramps Up with First Outside Funding
It’s a big month for Collabor, a Maynard, MA-based maker of software that powers online communities—for banks, nonprofits, manufacturers and a slew of industries in between. The company is working on closing its first ever outside funding round and has just cross the 1-million-user mark across the sites its technology powers. The five-year-old startup is … Continue reading “Collabor’s Software for Outward Collaboration at Businesses Ramps Up with First Outside Funding”
Rhythm Adds Former Merck VP as CEO
Merck veteran Keith Gottesdiener will become the new CEO of Boston-based Rhythm Pharmaceuticals, a Boston startup developing experimental drugs for the treatment of metabolic conditions such as obesity and diabetes, according to an announcement today. Gottesdiener oversaw pivotal clinical trials as Merck’s former vice president and late-sage therapeutic group leader, and is joining Rhythm as … Continue reading “Rhythm Adds Former Merck VP as CEO”
Best Buy Picks Up MindShift, Termeer Funds NanoString, Basho Adds $5M More, & More Boston-Area Deals News
This week’s roundup of New England deals includes companies working on vocal cord repair, cancer stem cells, database software, IT services, and drug counterfeiting prevention. —Prolific MIT professor and inventor Bob Langer is working on a new project with a Harvard University surgeon that’s aiming to repair damaged vocal cords. The vibrating gel they’re developing … Continue reading “Best Buy Picks Up MindShift, Termeer Funds NanoString, Basho Adds $5M More, & More Boston-Area Deals News”
Calcbench Looks to Help Budget-Minded Analysts Crunch Financial Data
Calcbench, a new startup working out of Cambridge, MA and New York, came to being from an app design challenge put on by the people behind XBRL, a technology standard the SEC requires public companies to use in reporting financial data. Yes, the terms app challenge and SEC did in fact appear in the same … Continue reading “Calcbench Looks to Help Budget-Minded Analysts Crunch Financial Data”
MindShift Acquired by Best Buy as Retailer Expands IT Services
Best Buy is looking to a local IT services firm to spruce up its business, announcing today that it is acquiring Waltham, MA-based MindShift Technologies for $167 million. The deal gives Best Buy (NYSE: [[ticker:BBY]]) more power behind its services offering as the company faces competition in its retail operation from online sources like Amazon. … Continue reading “MindShift Acquired by Best Buy as Retailer Expands IT Services”
Langer Nabs Cash From Rock Stars, Verastem Seeks $50M IPO, Alnylam Snags RNAi Collab, & More Boston-Area Life Sciences News
We’ve seen life sciences headlines from a mix of established drugmakers and universities in New England this week. —Waltham, MA-based Repligen is picking up a unit of the Danish industrial-biotech products maker Novozymes A/S for about $22.7 million in cash. Repligen (NASDAQ: [[ticker:RGEN]]) could also pay another roughly $5.6 million to the unit, Novozymes Biopharma … Continue reading “Langer Nabs Cash From Rock Stars, Verastem Seeks $50M IPO, Alnylam Snags RNAi Collab, & More Boston-Area Life Sciences News”
Deals Inked for Basho, Innocentive
Boston’s big data cluster recently got some attention at the MassTLC Innovation UnConference, and Basho Technologies, one of the companies in the space, followed up this week with a funding announcement. Check out that news and another IT financing below. —Basho, a Cambridge, MA-based developer of data storage and management software, announced it had pulled … Continue reading “Deals Inked for Basho, Innocentive”
Tru.ly’s Tech Takes a Crack at Verifying Online Identity for Liquor Websites, Gaming, Online Dating and More
Take a former D.C. lobbyist who’s now the owner of a chain of liquor stores, mix him with some security software engineers and you get Cambridge, MA-based Tru.ly. The startup’s software enables users to verify that they are who in fact they say they are online. Web users can apply for credentials via Tru.ly, with … Continue reading “Tru.ly’s Tech Takes a Crack at Verifying Online Identity for Liquor Websites, Gaming, Online Dating and More”
Patience, Honesty, and The Strings of Free Money: Five Financing Themes from the Seventh Annual Conference on Clean Energy
The relationship between venture capitalists and cleantech startups sure seems pretty lukewarm these days, at least from what I saw yesterday at the seventh Conference on Clean Energy in Boston. The lunchtime “VC” panel on cleantech funding 2.0 actually focused more on why venture capital isn’t necessarily the best move for financing transformative energy technologies, and … Continue reading “Patience, Honesty, and The Strings of Free Money: Five Financing Themes from the Seventh Annual Conference on Clean Energy”
Repligen Buys Novozymes Unit, World Energy Acquires GSE Consulting, Alnylam Partners With GSK, & More Boston-Area Deals News
The last week’s deals headlines have been shared among New England cleantech, IT, and life sciences companies. —Russian Federation fund Rusnano pumped money into two Bay State biotechs: Cambridge, MA-based BIND Biosciences and Watertown, MA-based Selecta Biosciences. Each startup got $25 million from Rusnano, a fund focused on nanotechnology investments, as well as $22.25 million … Continue reading “Repligen Buys Novozymes Unit, World Energy Acquires GSE Consulting, Alnylam Partners With GSK, & More Boston-Area Deals News”
Woes Mount for Local Energy Companies Beacon Power and American Superconductor
Things aren’t looking so sunny for Tyngsboro, MA-based Beacon Power (NASDAQ: [[ticker:BCON]]) and Devens, MA-based American Superconductor (NASDAQ: [[ticker:AMSC]]), a couple of prominent public companies in the cleantech sector. —Beacon Power, a flywheel energy storage company, filed documents seeking Ch. 11 bankruptcy protection. The move has shone some negative light on the U.S. Department of … Continue reading “Woes Mount for Local Energy Companies Beacon Power and American Superconductor”
Platform-as-a-Service Startup Mendix Pockets $13M Series A
[Updated 10/31/11 10:00 am. See below.] Mendix, a Boston-based developer of software platforms enabling business customers to develop, deploy, and manage applications, has announced its Series A round of funding. The $13 million financing was led by growth equity firm Prime Ventures, with participation by Mendix seed investor HENQ Invest. [Paragraph and headline updated because originally … Continue reading “Platform-as-a-Service Startup Mendix Pockets $13M Series A”
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News
It was a meaty New England life sciences week, with clinical advances, new funding, CEO hires, and acquisitions headlines. —Sanofi hired David Meeker as the new CEO of its Cambridge, MA-based Genzyme unit. Meeker, who got started at the company in 1994, will move into his new role on November 1 and will lead the … Continue reading “New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News”
Massachusetts Startup Investing Rose to $253.8M Last Month, Charged Up By Boston-Power’s $125M
There seems to be a theme in Massachusetts venture investing right now. Things aren’t quite as hot as they were earlier this year, but are still trumping last year’s numbers for the same period. That’s what my colleague Greg noted about the MoneyTree report for Q3 2011 venture investing. And that’s what I’ve observed here … Continue reading “Massachusetts Startup Investing Rose to $253.8M Last Month, Charged Up By Boston-Power’s $125M”
Atreaon and Arsenal Spinoff 480 Biomedical Nab Funds
Here are a couple of mid-week life sciences financings. —Watertown, MA-based Arsenal Medical, a developer of biomaterial-based scaffold and drug delivery products, announced it is spinning out a new company called 480 Biomedical. Both firms raised new funding ($15 million for 480 and $3 million for Arsenal) from Arsenal Medical’s return investors Polaris Venture Partners, … Continue reading “Atreaon and Arsenal Spinoff 480 Biomedical Nab Funds”
Hadapt Gets Series A, Cisco Buys BNI, Cubist Acquisition of Adolor Valued at $415M, & More Boston-Area Deals News
Financing rounds, acquisitions, and business plan prizes have made up the New England deals news this week. —Continuing the West-Coast-company-buys-East-Coast-company trend of last week, San Jose, CA-based Cisco Systems announced its purchase of Boxborough, MA-based BNI Video, a developer of software for managing cable content on the back end and improving the browsing experience for … Continue reading “Hadapt Gets Series A, Cisco Buys BNI, Cubist Acquisition of Adolor Valued at $415M, & More Boston-Area Deals News”
Xconomist of the Week: Joe Chung Says Redstar Ventures Is Creating Companies for “the TechCrunch Crowd’s Mothers”
“There’s sort of an infinite number of good ways to start a company,” says Xconomist Joe Chung. “One of the fundamental rules in startups is that there really aren’t any rules.” But the serial entrepreneur has some pretty specific plans for how his new creation will pop out startups. That would be Cambridge, MA-based Redstar … Continue reading “Xconomist of the Week: Joe Chung Says Redstar Ventures Is Creating Companies for “the TechCrunch Crowd’s Mothers””
Uber Hits Boston With Its Tech for Luxurious, On-the-Fly Rides
This is not your average cab company. In fact, it’s not a cab company at all. It’s a tech startup enabling urban luxury car services to function a bit more like cabs, while retaining their swank. It’s called Uber (formerly UberCab but renamed to avoid confusion) and it is up and running in Boston as … Continue reading “Uber Hits Boston With Its Tech for Luxurious, On-the-Fly Rides”
Bozuko Is Betting on Its Platform for Mobile Consumer Games to Drive Loyalty at Local Businesses
New Boston-area startup Bozuko is working at the intersection of a lot of big trends. Mobile. Gaming. Location-awareness. Software-as-a-service. Marketing promotions. Sound crowded? Company co-founder Jake Epstein says that people would rather play for a smaller chance to win something big than a guaranteed slim discount, and that’s what makes his business different from what’s … Continue reading “Bozuko Is Betting on Its Platform for Mobile Consumer Games to Drive Loyalty at Local Businesses”
Tolerx Shutters, Courtagen Gets $8M, OvaScience Emerges, & More Boston-Area Life Sciences News
We saw stories about New England life sciences companies in a range of stages this week: kicking off, shutting down, and growing. —Cambridge, MA-based biotech Tolerx will be shutting down its operations, after raising a total of more than $150 million from backers like HealthCare Ventures, Skyline Ventures, and Sprout Group. The company’s diabetes drug … Continue reading “Tolerx Shutters, Courtagen Gets $8M, OvaScience Emerges, & More Boston-Area Life Sciences News”
Clovr Changes Name to Linkable Networks, Nabs Investment from Citi Ventures to Push Card-Linked Offers
Less than a year after announcing its seed financing, Boston-based Clovr Media is changing its name to Linkable Networks and is adding another big-name investor to its roster. The digital media startup is announcing today that it has received an undisclosed investment from Palo Alto, CA- and Shanghai-based Citi Ventures, a unit of Citigroup. As … Continue reading “Clovr Changes Name to Linkable Networks, Nabs Investment from Citi Ventures to Push Card-Linked Offers”
Boston Xconomists and Area Innovators Gather for Special Xconomy Event: The Photos
As you may or may not know, it’s not just Xconomy’s staff editors who are powering our website with thoughtful reflections on the happenings in each of our city’s high-tech and innovation communities. We have more or less a dream team of innovators in each city who write for our Xconomist Forum, submitting posts on … Continue reading “Boston Xconomists and Area Innovators Gather for Special Xconomy Event: The Photos”
Incubator Payoff? TechStars, 500 Startups Alums Among the Tech Deals in the Last Week
We caught a fresh wave of tech startup financings, from companies working on improving e-mail, shopping, wellness, video surveillance, and enterprise computing. Here’s a quick rundown: —Boston-based HelpScout, developers of software for managing group collaboration across a single e-mail address, announced the closing of its $435,000 equity round. The TechStars Boston graduate told me when … Continue reading “Incubator Payoff? TechStars, 500 Startups Alums Among the Tech Deals in the Last Week”
Courtagen Grabs $8M, Nuance Buys Swype, OpenView Eyes Expansion Stage Investments, & More Boston-Area Deals News
The death of Steve Jobs dominated the tech news world in the last week, even on this coast, but we still saw some deals headlines from New England IT and life sciences players. —Agios Pharmaceuticals, a Cambridge, MA-based developer of cancer-starving drugs, added $20 million to the already $130 million collaboration it inked with New … Continue reading “Courtagen Grabs $8M, Nuance Buys Swype, OpenView Eyes Expansion Stage Investments, & More Boston-Area Deals News”
Courtagen Snaps Up $8M
Woburn, MA-based Courtagen Life Sciences, has pinned down an $8 million equity investment from 67 backers, an SEC filing shows. The company raised $7 million in Series A funding in August 2010, under its previous name Avantra Biosciences. Courtagen is developing protein biomarker technology for disease detection. The technology was purchased from the now-bankrupt Decision … Continue reading “Courtagen Snaps Up $8M”
Celgene Pays Agios $20M, Lycera Adds Cambridge CEO, Getinge Buys Atrium Medical, & More Boston-Area Life Sciences News
We saw a mix of personnel, drug partnership, and acquisition news from New England’s life sciences players this week. —Atrium Medical, a Hudson, NH-based developer of cardiology and radiology medical devices, is getting acquired by the Swedish firm, Getinge Group, for $680 million. Atrium will act as an independent business unit of the Getinge subsidiary … Continue reading “Celgene Pays Agios $20M, Lycera Adds Cambridge CEO, Getinge Buys Atrium Medical, & More Boston-Area Life Sciences News”
Three New England Teams Move on to Cleantech Open Finals in California
Plastic, oil, natural gas, paper, solar panels, analytics, semiconductors, blimps, mobile phones, wind turbines, smart grid. These were some of the words tossed around by the six teams presenting at last night’s Cleantech Open Northeast Regional Finals. Three companies were selected to go on and compete in the Cleantech Open Global Forum in California next … Continue reading “Three New England Teams Move on to Cleantech Open Finals in California”
EMC Picks Up Zettapoint, IBM Scoops Up Q1, Intel’s McAfee Acquires NitroSecurity, & More Boston-Area Deals NEws
New England area security, consumer Web, database, and medical device tech startups have been acquired by firms near and far at a feverish pace in the last week. —CustomMade, a Cambridge, MA-based provider of an online marketplace for connecting consumers with artisans, raised $2 million in funding from an unnamed group of investors. —A trio … Continue reading “EMC Picks Up Zettapoint, IBM Scoops Up Q1, Intel’s McAfee Acquires NitroSecurity, & More Boston-Area Deals NEws”
A Glimpse in Photos at the Xconomy Xchange: Consumers, the Cloud, and Beyond—New Rules for Innovation
VCs are wrong most of the time—and often it’s because they over-think a deal. That’s just one of the points I took away from our event this past Monday night, Xconomy Xchange: Consumers, the Cloud, and Beyond — New Rules for Innovation. If you want to catch some more themes from the panel—which featured venture capitalists … Continue reading “A Glimpse in Photos at the Xconomy Xchange: Consumers, the Cloud, and Beyond—New Rules for Innovation”
RXi Splits Up, Zeo Launches Mobile Sleep-Tracking App, Karuna Licenses Schizophrenia Compounds, & More Boston-Area Life Sciences News
This week’s New England life sciences news spanned companies targeting cancer, schizophrenia, sleep improvement, and genomic analysis. —Newton, MA-based health IT startup Zeo announced it added a mobile app version of its sleep tracking and coaching system. The company hopes the tool, which pushes sleep data gathered from a sensor-laden headband to a user’s mobile … Continue reading “RXi Splits Up, Zeo Launches Mobile Sleep-Tracking App, Karuna Licenses Schizophrenia Compounds, & More Boston-Area Life Sciences News”
Seed Funding, .300 Batting Averages, Overthinking Investments, & More Takeways from Xconomy’s Consumers, the Cloud, and Beyond
Here’s a good cure for the Mondays: an evening panel of venture capitalists whose collective portfolio includes companies like Zynga, DataXu, Backupify, HubSpot, Grockit, and more. I’m talking about our Xconomy Xchange: Consumers, the Cloud, and Beyond—New Rules for Innovation, held this past Monday night at WilmerHale in Boston. The panel featured Jeff Fagnan of … Continue reading “Seed Funding, .300 Batting Averages, Overthinking Investments, & More Takeways from Xconomy’s Consumers, the Cloud, and Beyond”
TechStars Pins Down $24M, Visible Measures Gets $13M Series D, Yesware Announces Seed Funding, & More Boston-Area Deals News
The IT space accounted for most of the deal-making we tracked in New England over the last week. —Boulder, CO-based TechStars said it pulled in $24 million in new funding, which will go to giving each company in its startup incubator programs (in Boulder, Boston, Seattle, and New York) another $100,000 in the form of … Continue reading “TechStars Pins Down $24M, Visible Measures Gets $13M Series D, Yesware Announces Seed Funding, & More Boston-Area Deals News”
Yesware Talks About Hiring Plans and Seed Funding from Google Ventures, Foundry Group
Yesware, the Cambridge, MA-based developer of e-mail plug-ins for salespeople, announced today that its $1 million first-round funding came from Google Ventures, Foundry Group, Golden Venture Partners, and angel investors Geoffrey Hyatt, Colby Wood, Mike Baker, David Cohen, Mike Dornbrook, and Will Herman. The money will go toward developing Yesware’s technology for helping salespeople contact … Continue reading “Yesware Talks About Hiring Plans and Seed Funding from Google Ventures, Foundry Group”
Zeo Introduces Sleep Manager Mobile, Shifting Focus from Hardware to Sleep Management Apps and Integration
There’s no shortage of mobile apps for managing your workout plans or counting calories, but far fewer for managing and improving sleep, says Ben Rubin, co-founder and chief technology officer of Newton, MA-based Zeo. And he has reason to know. The company’s Personal Sleep Coach system has won the support of Regis Philbin (TV endorsement), … Continue reading “Zeo Introduces Sleep Manager Mobile, Shifting Focus from Hardware to Sleep Management Apps and Integration”
This Week’s Xconomy Report for WGBH: Batteries, Incubators, Drugs & More
We’re a few weeks into our partnership with WGBH Radio to provide a weekly roundup of the week’s technology and innovation news and how it’s affecting the economy and other corners of our lives. This week’s Xconomy Report, read by WGBH’s Bob Seay, covered big cleantech and startup incubator financings, as well as deals for … Continue reading “This Week’s Xconomy Report for WGBH: Batteries, Incubators, Drugs & More”
Tokai Gets $23M, Eleven Therapeutics Hires New CEO, Ariad Drug Advances, & More Boston-Area Life Sciences News
This week’s New England life sciences news was dominated by area drugmakers. —Healthcare companies accounted for more than 75 percent of the $156.5 million brought in by Massachusetts startup companies in August, according to CB Insights FundingFlash. The overall monthly funding total has been shrinking since June, though. –Cambridge, MA-based prostate cancer drug developer Tokai … Continue reading “Tokai Gets $23M, Eleven Therapeutics Hires New CEO, Ariad Drug Advances, & More Boston-Area Life Sciences News”
FirstFuel Scores $2.4M to Put Toward Software for Remote Energy Audits
FirstFuel Software, a developer of energy auditing analytics technology for commercial buildings, announced today that it has nabbed $2.4 million in first round funding, led by Battery Ventures and Nth Power. The money will go to scaling and fueling customer adoption of FirstFuel’s software, which can profile the energy performance of buildings using data on … Continue reading “FirstFuel Scores $2.4M to Put Toward Software for Remote Energy Audits”
Mascoma Seeks IPO, Tokai Takes in $23M, Boston-Power Gets $125 for Shift to China, & More Boston-Area Deals News
This week’s deals news in New England was dominated by cleantech and life sciences firms. —Quincy, MA-based Bluefin Robotics, a maker of autonomous underwater vehicles, acquired the assets of Hawkes Remotes for an undisclosed sum. Hawkes Remotes is a spinoff of Hawkes Ocean Technologies, a Bay Area developer of deep-ocean explorer vehicles. —Providence, MA-based NABsys, … Continue reading “Mascoma Seeks IPO, Tokai Takes in $23M, Boston-Power Gets $125 for Shift to China, & More Boston-Area Deals News”
Boston-Power Pulls In $125M, Shifting Focus and Most Operations to China to Get Its Battery Tech into Electric Vehicles
Just after I wrote that no Massachusetts-based cleantech companies inked funding last month, Westborough-based Boston-Power bucks that trend for September. The developer of advanced lithium-ion battery technology is announcing today that it has raised $125 million. The deal, which brings Boston-Power’s total funding pot to more than $316 million, has some serious implications for the … Continue reading “Boston-Power Pulls In $125M, Shifting Focus and Most Operations to China to Get Its Battery Tech into Electric Vehicles”
What Bubble? August Startup Funding in MA Slides Further to $156.5M
The rate at which investors put money into startups continued to slow last month. Bay State tech and life sciences companies received $156.5 million across 27 equity-based deals, sinking further from the July total of $250.5 million. That’s according to data from FundingFlash, a daily roundup put out by CB Insights that tracks companies receiving … Continue reading “What Bubble? August Startup Funding in MA Slides Further to $156.5M”
Tensha Nabs $15M, Termeer Gives MIT $10M, Stata Puts $10M Into NABsys, & More Boston-Area Life Sciences News
We saw an interesting mix of financings, collaborations, and research news from New England’s drug and medical device developers this week. —HealthCare Ventures put $15 million in Series A funding into Cambridge, MA-based Tensha Therapeutics, a startup developing small-molecule drugs designed to treat cancer and other diseases by regulating the expression of disease-associated genes. —Boston’s … Continue reading “Tensha Nabs $15M, Termeer Gives MIT $10M, Stata Puts $10M Into NABsys, & More Boston-Area Life Sciences News”
Fraunhofer CSE, With Roots In Post-WWII Germany, Eyes South Boston Building as Energy Efficiency Test Bed
Building owners and managers are often reluctant to adopt new energy efficiency technology because they doubt it will be worth the cost in the long run. Nolan Browne, managing director of the Cambridge, MA-based (for now) Fraunhofer Center for Sustainable Energy Systems, is on the same page. “I fundamentally agree with them,” he says. “If … Continue reading “Fraunhofer CSE, With Roots In Post-WWII Germany, Eyes South Boston Building as Energy Efficiency Test Bed”
NABsys Takes in $10M Round, Led by Stata, for Gene Sequencing Tools
NABsys, a Providence, MA-based gene-sequencing startup, announced today it has closed a $10 million Series C investment led by return investor Stata Venture Partners, the Needham, MA-based firm founded by Analog Devices (NASDAQ: [[ticker:ADI]]) co-founder and chairman Ray Stata (a member of the NABsys board of directors). The new money, which brings NABsys’ total financing … Continue reading “NABsys Takes in $10M Round, Led by Stata, for Gene Sequencing Tools”
PerkinElmer Acquires Caliper for $600M, VideoIQ Nabs $7.5M, MC10 Snags $2.5M, & More Boston-Area Deals News
Seems like Cambridge, MA, is buzzing with dollar signs. Many of the financings we spotted this week went to life sciences and Web companies in the city. —MC10, a Cambridge-based developer of technology enabling electronics to bend and stretch, added $2.5 million in Series B funding, bringing the round’s total to $14.75 million. The new … Continue reading “PerkinElmer Acquires Caliper for $600M, VideoIQ Nabs $7.5M, MC10 Snags $2.5M, & More Boston-Area Deals News”
Brigham and Women’s Teams Up With GNS Healthcare to Fend Off Adverse Events in Heart Patients
Boston-based Brigham and Women’s Hospital and its Center for Patient Safety Research and Practice, led by David Bates, are announcing today a collaboration with GNS Healthcare to use supercomputing technology to improve patient care. Cambridge, MA-based GNS Healthcare’s computer-simulation models will be used to predict the likelihood of adverse drug events and hospital readmission in … Continue reading “Brigham and Women’s Teams Up With GNS Healthcare to Fend Off Adverse Events in Heart Patients”